Composition
| Ingredient | Strength |
|---|---|
| Dapagliflozin | 10 mg |
| Metformin Hydrochloride (extended release) | 500 mg |
Therapeutic use
Used in the management of type 2 diabetes mellitus. Dapagliflozin (an SGLT2 inhibitor) helps the kidneys remove excess glucose in urine.
For use under medical supervision only. Dosage, contraindications and precautions are as per the full prescribing information, available to registered medical practitioners on request.
Product details
- Brand name
- OJIDAP-M™
- Therapy range
- Diabetic
- Dosage form
- Tablet
- Pack size
- 10 x 10 tablets
- Number of ingredients
- 2
- Marketed by
- Grori Pharma Pvt Ltd
Frequently asked questions
What is the composition of Ojidap-M?
Each unit of Ojidap-M contains Dapagliflozin 10 mg + Metformin Hydrochloride (extended release) 500 mg.
What is Ojidap-M used for?
Used in the management of type 2 diabetes mellitus. Dapagliflozin (an SGLT2 inhibitor) helps the kidneys remove excess glucose in urine.
Who markets Ojidap-M?
Ojidap-M is marketed by Grori Pharma Pvt Ltd, Hyderabad, as part of its Diabetic range.
How can I get product information or place an order for Ojidap-M?
Doctors, pharmacies and distributors can call +91 95505 94814, +91 96528 45486 or +91 99669 45111, email groripharma@gmail.com, or use the enquiry form on the Grori Pharma contact page.